Skip to main content
ADIM logo

ADIM — Investor Relations & Filings

Ticker · 4142 ISIN · TW0004142005 LEI · 549300M5TV8YGVXU1827 TW Manufacturing
Open in API
Filings indexed 1,804 across all filing types
Latest filing 2026-05-14 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 4142

About ADIM

http://www.adimmune.com.tw/

ADIMMUNE CORPORATION, established in 1965, specializes in the research, development, and large-scale manufacturing of human vaccines and biologics. The company is a primary supplier of seasonal influenza and tetanus vaccines, maintaining production facilities that adhere to PIC/S GMP, US FDA, and EU standards. Its operations encompass the full product lifecycle, from initial R&D to commercial distribution. In addition to its proprietary vaccine portfolio, the company provides Contract Development and Manufacturing Organization (CDMO) services, supporting collaborative development and global supply chains. Recognized for its technical expertise in viral and bacterial vaccine production, the organization focuses on delivering high-quality immunization solutions to international markets while leveraging its history as a pioneering vaccine laboratory.

Recent filings

Filing Released Lang Actions
115年第1季財務報告書 — 202601_4142_AI1.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a consolidated financial report for the first quarter of the fiscal years (“民國115年及114年第一季”), including full interim balance sheet, income statement, cash flows, statement of changes in equity, notes and a CPA review (“會計師核閱報告”). This is substantive interim financial data, not merely an announcement or link to an external report, fitting the definition of an Interim/Quarterly Report. Q1 2026
2026-05-14 Chinese
114年第4季財務報告書 — 202504_4142_AIA.pdf
Audit Report / Information Classification · 95% confidence The document is a standalone set of consolidated financial statements accompanied by an independent auditor’s report for the years ended December 31, 2025 and 2024. It contains the auditors’ opinion, balance sheets, income statements, cash flow statements, notes, and declaration, but is not a full annual report (no management discussion or broader corporate overview). This matches the definition of an Audit Report / Information filing. FY 2025
2026-05-14 English
114年第4季財務報告書 — 202504_4142_AIC.pdf
Audit Report / Information Classification · 92% confidence The document consists of a full Independent Auditors’ Report translated from Chinese, including the auditor’s opinion, key audit matters, management and auditor responsibilities, followed by detailed parent-company-only financial statements (balance sheets, notes, etc.). This is a standalone audit report with accompanying financials rather than a full annual report or mere announcement. It therefore falls under the Audit Report / Information category. FY 2025
2026-05-14 English
115年第1季海外子公司投資
Interim / Quarterly Report Classification · 78% confidence The document originates from the Taiwanese public information observatory (“公開資訊觀測站”) and is titled “115年1季申報作業,” indicating a first‐quarter reporting schedule. It contains substantive financial data – a table of equity‐method investment balances and recognized gains/losses for the quarter end versus last year end. This is not merely an announcement of a report but actual quarter‐end figures, fitting the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-14 Chinese
115年第1季大陸投資
Regulatory Filings Classification · 85% confidence The document is a short schedule disclosing the company's investments in mainland China (cross-strait investment table) filed on Taiwan’s Public Information Observatory. It contains no narrative management discussion, no full financial statements, and is not an AGM/earnings/annual report or other specific category. It is a standalone regulatory disclosure, so it falls under Regulatory Filings (RNS) as the catch-all for miscellaneous compliance filings.
2026-05-14 Chinese
115年第1季權益變動表
Interim / Quarterly Report Classification · 92% confidence The document is titled “合併權益變動表” (Consolidated Statement of Changes in Equity) for 民國115年第1季 and the prior year’s first quarter, showing detailed quarterly financial data and actual figures. It is part of an interim/quarterly financial report containing substantive financial statements, not merely an announcement. This matches the definition of a comprehensive Interim / Quarterly Report. Q1 2026
2026-05-14 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.